INCR 1.49 (+11.19%)
IL0011063760Drug ManufacturersDrug Manufacturers - Specialty & Generic

Intercure (INCR) Competitor Comparison

We are evaluating the key criteria listed to compare Intercure (INCR) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 5 years - INCR ranking 0 / 54

These are the competitors of Intercure in the industry Drug Manufacturers - Specialty & Generic ranked by performance 5 years
1. Harrow Health HROW
403.24
2. Teva Pharmaceutical Industries TEVA
121.34
3. Amphastar Pharmaceuticals AMPH
98.88
4. Avadel Pharmaceuticals AVDL
64.96
5. Amneal Pharmaceuticals AMRX
64.14
6. Supernus Pharmaceuticals SUPN
50.57
7. Collegium Pharmaceutical COLL
47.91
8. Kolinpharma KIP.MI
42.45
9. Vifor Pharma G2AB.F
39.09
10. Zoetis ZTS
27.41
11. Alvotech ALVO
25.37
12. PetIQ PETQ
23.72
13. Alimera Sciences ALIM
23.11
14. Catalent CTLT
19.28
15. Green Thumb Industries R9U2.F
4.93
16. Phibro Animal Health PAHC
-12.29
17. Evolus EOLS
-12.88
18. Kamada KMDA
-15.47
19. ANI Pharmaceuticals ANIP
-17.92
20. Organogenesis Holdings ORGO
-39.6
21. Journey Medical DERM
-46.21
22. Linc LNC
-48.9
23. Taro Pharmaceutical Industries TARO
-50.4
24. Perrigo PRGO
-53.11
25. ProPhase Labs PRPH
-56.67
26. Cumberland Pharmaceuticals CPIX
-57.81
27. Embecta EMBC
-57.85
28. Regencell Bioscience Holdings RGC
-59
29. Pacira BioSciences PCRX
-59.6
30. Elanco Animal Health ELAN
-59.76
31. Alpha Teknova TKNO
-62.69
32. Ironwood Pharmaceuticals IRWD
-67.11
33. Neoleukin Therapeutics NLTX
-70.42
34. Cronos Group CRON
-72.02
35. Curaleaf Holdings CURLF
-72.66
36. Bausch Health Companies BHC
-75.09
37. Jupiter Wellness JUPW
-80
38. Zynerba Pharmaceuticals ZYNE
-82.07
39. Theratechnologies THTX
-83.9
40. Emergent BioSolutions EBS
-84.97
41. Societal CDMO SCTL
-85.58
42. Ayr Wellness 3KJB.F
-86.37
43. SCYNEXIS SCYX
-86.49
44. Ascend Wellness Holdings AAWH
-89.54
45. OptiNose OPTN
-90.87
46. Procaps Group PROC
-91.37
47. Tilray Brands TLRY
-92.7
48. Solid Biosciences SLDB
-93.33
49. Universe Pharmaceuticals UPC
-98.29
50. Relmada Therapeutics RLMD
-98.35
51. Eagle Pharmaceuticals EGRX
-98.48
52. Biofrontera BFRI
-98.78
53. Flora Growth FLGC
-99.09
54. Clever Leaves Holdings CLVR
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.